{
  "ticker": "STOK",
  "company_name": "Stoke Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04740476",
      "title": "An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Dravet Syndrome",
      "start_date": "2021-01-20",
      "completion_date": "2029-03-31",
      "enrollment": 0,
      "sponsor": "Stoke Therapeutics, Inc"
    },
    {
      "nct_id": "NCT04442295",
      "title": "An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Dravet Syndrome",
      "start_date": "2020-06-29",
      "completion_date": "2023-11-14",
      "enrollment": 0,
      "sponsor": "Stoke Therapeutics, Inc"
    },
    {
      "nct_id": "NCT06872125",
      "title": "A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Dravet Syndrome",
      "start_date": "2025-06-04",
      "completion_date": "2027-08",
      "enrollment": 0,
      "sponsor": "Stoke Therapeutics, Inc"
    }
  ],
  "summary": {
    "total_trials": 3,
    "by_phase": {
      "PHASE2": 1,
      "PHASE1, PHASE2": 1,
      "PHASE3": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 1,
      "COMPLETED": 1,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 1,
    "conditions": [
      "Dravet Syndrome"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:06.302701",
    "search_query": "Stoke Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Stoke+Therapeutics,+Inc."
  }
}